Desvenlafaxine (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Desvenlafaxine drug offered from Actavis Pharma, Inc.. This Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Desvenlafaxine |
SUBSTANCE NAME: | DESVENLAFAXINE SUCCINATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
Desvenlafaxine HUMAN PRESCRIPTION DRUG Details:
Item Description | Desvenlafaxine from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-3659_423973f5-97cc-40a3-a099-853cdb3a9b70 |
PRODUCT NDC: | 0591-3659 |
APPLICATION NUMBER: | ANDA204065 |
Other DESVENLAFAXINE SUCCINATE Pharmaceutical Manufacturers / Labelers: